Company Profiles

driven by the PitchBook Platform

Lipella Pharmaceuticals

Description

Developer of products for trans-mucosal therapy. The company develops drugs for several urinary bladder diseases that affect millions of people worldwide. Its therapeutic focuses on urology, otorhinolaryngology, gastroenterology and dermatology.

2005

Founded

PRIVATE

Status

1-10

Employees

Grant

Latest Deal Type

$4M

Latest Deal Amount

$701k

Total Amount Raised

Description

Developer of products for trans-mucosal therapy. The company develops drugs for several urinary bladder diseases that affect millions of people worldwide. Its therapeutic focuses on urology, otorhinolaryngology, gastroenterology and dermatology.

Website:

www.lipella.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

400 North Lexington Avenue LL103 Pittsburgh, PA 15208United States +1 (412) 894-1853
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Lipella Pharmaceuticals's full profile, request a free trial.

Lipella Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Lipella Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Lipella Pharmaceuticals Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Individual InvestorAngel (individual)Minority000 0000000 0000
Pittsburgh Life Sciences GreenhouseVenture CapitalMinority000 0000000 0000
The National Institute of Diabetes and Digestive and Kidney DiseasesGovernment000 0000000 0000
Individual Investor Angel (individual)
Pittsburgh Life Sciences Greenhouse Venture Capital
The National Institute of Diabetes and Digestive and Kidney Diseases Government

Lipella Pharmaceuticals Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Kirk FrenchChief Financial Officer
David ChancellorDirector, Marketing
Michelle GruberDirector, Operations
Michael Chancellor MDCo-Founder, Chief Medical Officer, Board Member & Executive Vice President
Kirk French Chief Financial Officer
David Chancellor Director, Marketing
Michelle Gruber Director, Operations
Michael Chancellor MD Co-Founder, Chief Medical Officer, Board Member & Executive Vice President

Lipella Pharmaceuticals Board Members (3)

NameRepresentingRoleSinceContact
Info
David BattlemanSelfBoard Member000 0000
David LucchinoSelfBoard Member000 0000
Thomas Petzinger Jr.SelfBoard Member000 0000
David Battleman Board Member Self
David Lucchino Board Member Self
Thomas Petzinger Jr. Board Member Self
Request full access to PitchBook